HTLV-1 Infection and Rheumatic Diseases

Risk of Human T-Cell Leukemia Virus Type 1 Infection in Kidney Transplantation

(2019) Junji Yamauchi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical features and human T-cell leukemia virus type-1 (HTLV-1) proviral load in HTLV-1-positive patients with rheumatoid arthritis: Baseline data in a single center cohort study

(2019) Katsumi Eguchi et al.   Modern Rheumatology

Neuroimmunology of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis

(2019) Satoshi Nozuma et al.   Frontiers in Microbiology

Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL

(2019) Mari Kannagi et al.   Retrovirology

Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan

(2019) Shuntaro Tsutsumi et al.   Orphanet Journal of Rare Diseases

Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies

(2019) Gill Schierhout et al.   LANCET INFECTIOUS DISEASES

Rheumatoid arthritis and lymphoma: Incidence, pathogenesis, biology, and outcome

(2018) Alina Klein et al.   HEMATOLOGICAL ONCOLOGY

Adult T-cell Leukemia/Lymphoma as a Methotrexate-associated Lymphoproliferative Disorder in a Patient with Rheumatoid Arthritis

(2018) Ichiro Takajo et al.   INTERNAL MEDICINE

Brief Report: Attenuated Effectiveness of Tumor Necrosis Factor Inhibitors for Anti-Human T Lymphotropic Virus Type I Antibody-Positive Rheumatoid Arthritis

(2018) Takahisa Suzuki et al.   Arthritis & Rheumatology

The time-sequential changes of risk factors for adult T-cell leukemia development in human T-cell leukemia virus-positive patients with rheumatoid arthritis: a retrospective cohort study

(2018) Kunihiko Umekita et al.   Modern Rheumatology

Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases

(2018) Nicolas Futsch et al.   Viruses-Basel

Novel treatment strategies in rheumatoid arthritis

(2017) Gerd R Burmester et al.   LANCET

Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions

(2017) Yukiko Terada et al.   MEDICINE

Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis

(2016) Masahiro Satake et al.   LANCET INFECTIOUS DISEASES

Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjögren’s syndrome

(2015) Hideki Nakamura et al.   BMC MUSCULOSKELETAL DISORDERS

Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study

(2015) Youko Suehiro et al.   BRITISH JOURNAL OF HAEMATOLOGY

Inflammatory manifestations of HTLV-1 and their therapeutic options

(2014) Fabiola Martin et al.   Expert Review of Clinical Immunology

Development of Adult T-cell Leukemia in a Patient with Rheumatoid Arthritis Treated with Tocilizumab

(2014) Hideki Nakamura et al.   INTERNAL MEDICINE

HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells

(2014) Natsumi Araya et al.   JOURNAL OF CLINICAL INVESTIGATION

Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy

(2013) Hitoshi Ando et al.   BRAIN

Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression

(2013) Ayako Ichikawa et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Adult T-cell leukemia/lymphoma triggered by adalimumab

(2013) Achilea L Bittencourt et al.   JOURNAL OF CLINICAL VIROLOGY

Use of anti-tumor necrosis factor biologics in the treatment of rheumatoid arthritis does not change human T-lymphotropic virus type 1 markers: a case series

(2013) Kunihiko Umekita et al.   Modern Rheumatology

Treatment With Anti-Tumor Necrosis Factor Biologic Agents in Human T Lymphotropic Virus Type I-Positive Patients With Rheumatoid Arthritis

(2013) Kunihiko Umekita et al.   ARTHRITIS CARE & RESEARCH

HTLV-1 bZIP Factor Induces Inflammation through Labile Foxp3 Expression

(2013) Nanae Yamamoto-Taguchi et al.   PLoS Pathogens

Proviral loads of human T-lymphotropic virus Type 1 in asymptomatic carriers with different infection routes

(2011) Shiro Ueno et al.   INTERNATIONAL JOURNAL OF CANCER

Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): the ATL Prevention Program Nagasaki

(2011) Shigeo HINO   PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers

(2011) Ayako Takamori et al.   Retrovirology

HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo

(2011) Yorifumi Satou et al.   PLoS Pathogens

Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan

(2010) M. Iwanaga et al.   BLOOD

Abnormally High Levels of Virus-Infected IFN-γ+CCR4+CD4+CD25+ T Cells in a Retrovirus-Associated Neuroinflammatory Disorder

(2009) Yoshihisa Yamano et al.   PLoS One

The Elevated Interferon Gamma Production is an Important Immunological Marker in HAM/TSP Pathogenesis

(2009) P. A. Montanheiro et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY